How has Aurinia Pharmaceuticals's change in deferred revenue changed year-over-year?

Aurinia Pharmaceuticals's change in deferred revenue decreased by 75.1% year-over-year, from $4.34M to $1.08M.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Aurinia Pharmaceuticals AUPH Change in Deferred Revenue

Change in Deferred Revenue at other companies

Ultragenyx PharmaceuticalRARE

$0+100%

Alumis Inc.ALMS

$2.26M-13.5%

Arrowhead ResearchARWR

$163.36M—

ALN

Alnylam PharmaceuticalsALNY

-$1.63M+94.0%

Ligand PharmaceuticalsLGND

$0+100%

BridgeBio PharmaBBIO

-$2.38M+7.5%

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's change in deferred revenue?: Aurinia Pharmaceuticals (AUPH) reported change in deferred revenue of $1.08M in Q1 2026.
How has Aurinia Pharmaceuticals's change in deferred revenue changed year-over-year?: Aurinia Pharmaceuticals's change in deferred revenue decreased by 75.1% year-over-year, from $4.34M to $1.08M.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.